Suppr超能文献

比较肝组织、肝细胞和细胞系中游离分数的物种和细胞类型差异。

Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines.

机构信息

Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut (K.R., S.R., J.L., D.S., B.R.H., B.K., G.C., L.D.); and Early Clinical Development (P.Y.), and Pharmacokinetics, Dynamics and Metabolism (D.T., R.L.), Pfizer Inc., Cambridge, Massachusetts.

Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut (K.R., S.R., J.L., D.S., B.R.H., B.K., G.C., L.D.); and Early Clinical Development (P.Y.), and Pharmacokinetics, Dynamics and Metabolism (D.T., R.L.), Pfizer Inc., Cambridge, Massachusetts

出版信息

Drug Metab Dispos. 2018 Apr;46(4):415-421. doi: 10.1124/dmd.117.079152. Epub 2018 Feb 2.

Abstract

Fraction unbound () of liver tissue, hepatocytes, and other cell types is an essential parameter used to estimate unbound liver drug concentration and intracellular free drug concentration. and are frequently measured in multiple species and cell types in drug discovery and development for various applications. A comparison study of 12 matrices for and of hepatocytes in five different species (mouse, rat, dog, monkey, and human), as well as of Huh7 and human embryonic kidney 293 cell lines, was conducted for 22 structurally diverse compounds with the equilibrium dialysis method. Using an average bioequivalence approach, our results show that the average difference in binding to liver tissue, hepatocytes, or different cell types was within 2-fold of that of the rat Therefore, we recommend using rat as a surrogate for liver binding in other species and cell types in drug discovery. This strategy offers the potential to simplify binding studies and reduce cost, thereby enabling a more effective and practical determination of for liver tissues, hepatocytes, and other cell types. In addition, under hepatocyte stability incubation conditions should not be confused with , as one is a diluted and the other is an undiluted Cell density also plays a critical role in the accurate measurement of .

摘要

肝组织、肝细胞和其他细胞类型的未结合分数()是用于估计未结合肝药物浓度和细胞内游离药物浓度的重要参数。在药物发现和开发的各种应用中,经常在多个物种和细胞类型中测量和。使用平衡透析法对来自五种不同物种(小鼠、大鼠、狗、猴子和人)的肝细胞以及 Huh7 和人胚肾 293 细胞系的 12 种基质中的和进行了 22 种结构多样的化合物的比较研究。使用平均生物等效性方法,我们的结果表明,与大鼠相比,与肝组织、肝细胞或不同细胞类型结合的平均差异在 2 倍以内。因此,我们建议在药物发现中使用大鼠作为其他物种和细胞类型肝结合的替代物。该策略具有简化结合研究和降低成本的潜力,从而能够更有效地确定肝组织、肝细胞和其他细胞类型的。此外,在肝细胞稳定性孵育条件下的不应与混淆,因为一个是稀释的,另一个是未稀释的。细胞密度在准确测量中也起着关键作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验